Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of BOTOX and Solifenacin in Overactive Bladder With Urinary Incontinence
2012-003255-11Phase 3Completed
- Sponsor
- Allergan
- Start
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in overactive bladder (OAB), urinary incontinence (UI), sponsored by Allergan. Started Mar 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on 2012-003255-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003255-11.